BDBM243180 (R)-N-(1-(5-Azaspiro[2.4]heptan-5- yl)propan-2-yl)-4-(5-(trifluoromethyl)- 1,2,4-oxadiazol-3-yl)benzamide::US10053434, 15
SMILES: C[C@H](CN1CCC2(CC2)C1)NC(=O)c1ccc(cc1)-c1noc(n1)C(F)(F)F
InChI Key: InChIKey=VGTHJSZAAWBZKN-GFCCVEGCSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HDAC4 (Homo sapiens (Human)) | BDBM243180 ((R)-N-(1-(5-Azaspiro[2.4]heptan-5- yl)propan-2-yl)...) | PDB GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
CHDI FOUNDATION, INC. US Patent | Assay Description 5 μL of each solution of 1:20 diluted compound from above was transferred to a clear bottomed, black, 384-well assay plate using the Bravo or th... | US Patent US10053434 (2018) BindingDB Entry DOI: 10.7270/Q2MG7RJZ | |||||||||||
More data for this Ligand-Target Pair |